The aim of this study is to evaluate the efficacy and safety of the New.COV2.S vaccine for the prevention of Covid-19 associated with SARS-CoV-2 infection.
MissionTEC has been mandated to carry out the necessary tasks for the follow-up of the study in the patients’ homes.